Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function and Adults With Severe Hepatic Impairment
Clinical trial NCT02296853 · COMPLETED
Trial details
- NCT number
- NCT02296853
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-22
- Primary completion
- 2015-04-17
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.